期刊
MUSCLE & NERVE
卷 39, 期 6, 页码 849-850出版社
WILEY
DOI: 10.1002/mus.21306
关键词
adverse effect; autoimmune disease; CellCept; myasthenia gravis; mycophenolate mofetil
Immunosuppressive therapies are critical in the management of numerous conditions including myasthenia gravis. Mycophenolate mofetil is a widely used, oral immunosuppressive agent that is considered to have few adverse effects compared with similar drugs. We report the case of a patient who developed T-cell lymphoproliferative lesions following long-term treatment with mycophenolate mofetil and prednisone for myasthenia gravis. The lesions resolved following cessation of the treatment. This case highlights a serious complication of a commonly used drug. Muscle Nerve 39: 849-850, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据